Publications
Developing an RNase-free bioprocess to produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane chromatography. Separation and Purification Technology, 83, 121-129.
(2011). Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system. Biotechnology Advances, 29, 923-929. 2011_disulfide_bond_formation.pdf
. (2011). Molecular manipulation associated with disulfide bond formation to enhance the stability of recombinant therapeutic protein. Protein Expression and Purification, 75, 28-39.
. (2011). Potential application of hydrogel-based strong anion-exchange membrane for plasmid DNA purification. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 879, 564-572.
(2011). Biochemical and genetic engineering strategies to enhance hydrogen production in photosynthetic algae and cyanobacteria. Bioresource Technology, 102, 8589-8604. 2011_biochemical_and_genetic_engineering_strategies_to_enhance_hydrogen_production_in_photosynthetic_algae_and_cyanobacteria.pdf
. (2011). Enhancing Functional Expression of Heterologous Burkholderia Lipase in Escherichia coli. Molecular Biotechnology, 47, 130-143.
. (2011). Developing an Extended Genomic Engineering Approach Based on Recombineering to Knock-in Heterologous Genes to Escherichia coli Genome. Molecular Biotechnology, 51, 109-118.
. (2012). Towards sustainable production of clean energy carriers from biomass resources. Applied Energy, 100, 172-186. 2012_towards_sustainable_production_of_clean_energy_carriers_from_biomass_resources.pdf
. (2012). Simultaneous clarification of Escherichia coli culture and purification of extracellularly produced penicillin G acylase using tangential flow filtration and anion-exchange membrane chromatography (TFF-AEMC). Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 900, 71-78.
(2012). (2012). Biotechnological advances on Penicillin G acylase: Pharmaceutical implications, unique expression mechanism and production strategies. Biotechnology Advances, 31, 1319-1332. 2013_biotechnological_advances_on_penicillin_g_acylase_pharmaceutical_implications_unique_expression_mechanism_and_production_strategies.pdf
. (2013). Development of an electrotransformation protocol for genetic manipulation of Clostridium pasteurianum. Biotechnology for Biofuels, 6. 2013_development_of_an_electrotransformation_protocol_for_genetic_manipulation_of_clostridium_pasteurianum.pdf
. (2013). (2013). . (2013). Improved Draft Genome Sequence of Clostridium pasteurianum Strain ATCC 6013 (DSM 525) Using a Hybrid Next-Generation Sequencing Approach. Genome announcements, 2, e00790-14.
. (2014). Application of a two-dimensional disposable rocking bioreactor to bacterial cultivation for recombinant protein production. Biochemical Engineering Journal, 88, 154-161.
. (2014). Biochemical, genetic, and metabolic engineering strategies to enhance coproduction of 1-propanol and ethanol in engineered Escherichia coli. Applied Microbiology and Biotechnology, 98, 9499-9515. 2014bi2.pdf
. (2014). Expansion of the genetic toolkit for metabolic engineering of Clostridium pasteurianum: chromosomal gene disruption of the endogenous CpaAI restriction enzyme. Biotechnology for Biofuels, 7. 2014ex1.pdf
. (2014). Technical guide for genetic advancement of underdeveloped and intractable Clostridium. Biotechnology Advances, 32, 623-641. 2014_technical_guide_for_genetic_advancement_of_underdeveloped_and_intractable_clostridium.pdf
. (2014). Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli. Journal of Industrial Microbiology & Biotechnology, 41, 947-956.
. (2014).